Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin-based triple therapy (Q39014381)

8 September 2017

Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin-based triple therapy (English)

1 reference

8 September 2017

0 references

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Takahisa Furuta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Mitsushige Sugimoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Mihoko Yamade

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Takahiro Uotani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Shu Sahara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Hitomi Ichikawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Takanori Yamada

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ken Sugimoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Hiroshi Watanabe

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Kazuo Umemura

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

22 October 2013

1 reference

The Journal of Clinical Pharmacology

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

258-266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection

1 June 2020

cites work

1 reference

Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin

21 January 2018

1 reference

Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration

21 January 2018

1 reference

Pharmacokinetic considerations in the eradication of Helicobacter pylori

21 January 2018

1 reference

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid

21 January 2018

1 reference

Proof of concept: performance testing in models

21 January 2018

1 reference

A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin

21 January 2018

1 reference

High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection

21 January 2018

1 reference

Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori

21 January 2018

1 reference

Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection

21 January 2018

1 reference

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

21 January 2018

1 reference

Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

21 January 2018

1 reference

Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States

21 January 2018

1 reference

Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities

21 January 2018

1 reference

Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance

21 January 2018

1 reference

A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients

21 January 2018

1 reference

Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population

21 January 2018

1 reference

Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCPH.195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122836%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference